29.53
price down icon1.57%   -0.47
pre-market  Vorhandelsmarkt:  29.98   0.45   +1.52%
loading
Schlusskurs vom Vortag:
$30.00
Offen:
$29.75
24-Stunden-Volumen:
554.71K
Relative Volume:
1.84
Marktkapitalisierung:
$488.36M
Einnahmen:
$3.25M
Nettoeinkommen (Verlust:
$-116.80M
KGV:
-9.682
EPS:
-3.05
Netto-Cashflow:
$-98.17M
1W Leistung:
+0.65%
1M Leistung:
+23.30%
6M Leistung:
+322.15%
1J Leistung:
+108.55%
1-Tages-Spanne:
Value
$28.86
$30.00
1-Wochen-Bereich:
Value
$25.50
$42.39
52-Wochen-Spanne:
Value
$5.6652
$42.39

Rapt Therapeutics Inc Stock (RAPT) Company Profile

Name
Firmenname
Rapt Therapeutics Inc
Name
Telefon
(650) 489-9000
Name
Adresse
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
Name
Mitarbeiter
61
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
RAPT's Discussions on Twitter

Vergleichen Sie RAPT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RAPT
Rapt Therapeutics Inc
29.53 496.13M 3.25M -116.80M -98.17M -3.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.39 108.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.43 60.82B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.95 61.02B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
817.32 50.01B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.81 34.05B 4.56B -176.77M 225.30M -1.7177

Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-20 Hochstufung JP Morgan Neutral → Overweight
2025-10-13 Eingeleitet Barclays Overweight
2025-09-26 Hochstufung Leerink Partners Market Perform → Outperform
2025-07-30 Hochstufung JP Morgan Underweight → Neutral
2025-05-22 Fortgesetzt H.C. Wainwright Buy
2024-12-26 Hochstufung H.C. Wainwright Neutral → Buy
2024-11-13 Herabstufung Stifel Buy → Hold
2024-11-11 Herabstufung JP Morgan Neutral → Underweight
2024-11-11 Herabstufung Piper Sandler Overweight → Neutral
2024-05-14 Herabstufung Wolfe Research Outperform → Peer Perform
2024-05-10 Herabstufung Barclays Overweight → Equal Weight
2024-05-10 Herabstufung Guggenheim Buy → Neutral
2024-02-22 Herabstufung UBS Buy → Neutral
2024-02-21 Herabstufung H.C. Wainwright Buy → Neutral
2024-02-21 Herabstufung JP Morgan Overweight → Neutral
2024-02-21 Herabstufung Leerink Partners Outperform → Market Perform
2024-02-20 Herabstufung Cantor Fitzgerald Overweight → Neutral
2024-02-16 Eingeleitet Evercore ISI Outperform
2024-02-15 Eingeleitet Wolfe Research Outperform
2023-09-14 Eingeleitet Berenberg Buy
2023-08-09 Eingeleitet Stifel Buy
2023-06-15 Eingeleitet Barclays Overweight
2023-01-04 Eingeleitet Guggenheim Buy
2022-12-01 Eingeleitet Goldman Buy
2022-09-21 Eingeleitet CapitalOne Overweight
2022-05-24 Fortgesetzt Cantor Fitzgerald Overweight
2021-12-09 Eingeleitet JP Morgan Overweight
2021-08-12 Eingeleitet SVB Leerink Outperform
2021-06-21 Eingeleitet Piper Sandler Overweight
2020-06-01 Eingeleitet H.C. Wainwright Buy
2020-05-19 Eingeleitet Cantor Fitzgerald Overweight
2020-04-13 Eingeleitet ROTH Capital Buy
2019-11-25 Eingeleitet BMO Capital Markets Outperform
2019-11-25 Eingeleitet UBS Buy
2019-11-25 Eingeleitet Wells Fargo Outperform
Alle ansehen

Rapt Therapeutics Inc Aktie (RAPT) Neueste Nachrichten

pulisher
04:37 AM

Analyzing RAPT Therapeutics Inc. with multi timeframe chartsQuarterly Earnings Report & Verified Trade Idea Suggestions - newser.com

04:37 AM
pulisher
04:29 AM

Why retail investors favor RAPT Therapeutics Inc. stockIPO Watch & Weekly Watchlist for Hot Stocks - newser.com

04:29 AM
pulisher
04:00 AM

Tick level data insight on RAPT Therapeutics Inc. volatilityWeekly Earnings Recap & AI Driven Stock Price Forecasts - newser.com

04:00 AM
pulisher
03:59 AM

Risk adjusted return profile for RAPT Therapeutics Inc. analyzedDividend Hike & AI Enhanced Trade Execution Alerts - newser.com

03:59 AM
pulisher
03:57 AM

Published on: 2025-10-27 02:57:37 - newser.com

03:57 AM
pulisher
03:53 AM

Can RAPT Therapeutics Inc. recover in the next quarterPortfolio Risk Summary & Comprehensive Market Scan Reports - newser.com

03:53 AM
pulisher
03:20 AM

Is RAPT Therapeutics Inc. stock a buy for dividend growthJuly 2025 Recap & Fast Gain Swing Alerts - newser.com

03:20 AM
pulisher
02:15 AM

What indicators show strength in RAPT Therapeutics Inc.Trade Performance Summary & Consistent Profit Focused Trading Strategies - newser.com

02:15 AM
pulisher
01:59 AM

Published on: 2025-10-27 00:59:41 - newser.com

01:59 AM
pulisher
12:33 PM

Does RAPT Therapeutics Inc. (0RA) stock trade below intrinsic value2025 Analyst Calls & Momentum Based Trading Signals - newser.com

12:33 PM
pulisher
12:23 PM

Published on: 2025-10-26 23:23:14 - newser.com

12:23 PM
pulisher
Oct 26, 2025

Is RAPT Therapeutics Inc. stock reversal real or fakeDay Trade & Reliable Breakout Stock Forecasts - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 21:27:10 - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 20:42:00 - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Why RAPT Therapeutics Inc. (0RA) stock could break out in 2025Quarterly Earnings Report & Technical Entry and Exit Alerts - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Is RAPT Therapeutics Inc. (0RA) stock dividend growth reliableJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 15:06:18 - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Leading vs lagging indicators on RAPT Therapeutics Inc. performanceInsider Selling & Technical Entry and Exit Tips - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 10:44:52 - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Wells Fargo Boosts RAPT Therapeutics (RAPT) PT to $48 on Promising Anti-IgE Drug Data - Insider Monkey

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 00:53:27 - newser.com

Oct 26, 2025

Finanzdaten der Rapt Therapeutics Inc-Aktie (RAPT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.26
price up icon 1.11%
$91.28
price up icon 2.21%
$29.89
price up icon 0.07%
$105.66
price up icon 0.87%
$159.66
price down icon 0.29%
biotechnology ONC
$310.81
price up icon 0.25%
Kapitalisierung:     |  Volumen (24h):